The Joint Corp. (NASDAQ:JYNT) has earned an average rating of “Buy” from the six analysts that are presently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $6.15.

Several analysts have recently weighed in on JYNT shares. ValuEngine raised The Joint Corp. from a “sell” rating to a “hold” rating in a report on Tuesday, June 6th. Craig Hallum started coverage on The Joint Corp. in a report on Wednesday, June 14th. They issued a “buy” rating and a $5.75 target price for the company. Roth Capital started coverage on The Joint Corp. in a report on Thursday, July 27th. They issued a “buy” rating and a $5.70 target price for the company. Finally, Maxim Group reissued a “buy” rating and issued a $7.00 target price on shares of The Joint Corp. in a report on Friday, August 11th.

In other news, Director James H. Amos, Jr. bought 10,000 shares of The Joint Corp. stock in a transaction dated Friday, June 30th. The stock was acquired at an average cost of $3.85 per share, with a total value of $38,500.00. Following the acquisition, the director now owns 57,295 shares of the company’s stock, valued at $220,585.75. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO John P. Meloun bought 6,850 shares of The Joint Corp. stock in a transaction dated Tuesday, June 27th. The stock was purchased at an average cost of $3.69 per share, with a total value of $25,276.50. The disclosure for this purchase can be found here. Insiders bought a total of 20,670 shares of company stock valued at $78,140 over the last three months. Company insiders own 6.10% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Captrust Financial Advisors purchased a new stake in The Joint Corp. during the 2nd quarter valued at approximately $791,000. White Pine Capital LLC raised its stake in The Joint Corp. by 44.2% during the 2nd quarter. White Pine Capital LLC now owns 55,500 shares of the company’s stock valued at $211,000 after acquiring an additional 17,000 shares during the last quarter. Boston Partners raised its stake in The Joint Corp. by 13.1% during the 2nd quarter. Boston Partners now owns 150,900 shares of the company’s stock valued at $573,000 after acquiring an additional 17,500 shares during the last quarter. Russell Investments Group Ltd. raised its stake in The Joint Corp. by 24.9% during the 2nd quarter. Russell Investments Group Ltd. now owns 87,900 shares of the company’s stock valued at $334,000 after acquiring an additional 17,500 shares during the last quarter. Finally, Sanders Morris Harris LLC raised its stake in The Joint Corp. by 0.5% during the 2nd quarter. Sanders Morris Harris LLC now owns 2,619,807 shares of the company’s stock valued at $9,955,000 after acquiring an additional 12,000 shares during the last quarter. 47.03% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “The Joint Corp. (JYNT) Given Consensus Recommendation of “Buy” by Analysts” was published by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was illegally copied and reposted in violation of international trademark and copyright law. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/09/15/the-joint-corp-jynt-given-consensus-recommendation-of-buy-by-analysts.html.

The Joint Corp. (NASDAQ:JYNT) opened at 4.70 on Friday. The stock’s market capitalization is $61.94 million. The stock has a 50 day moving average price of $4.09 and a 200 day moving average price of $3.92. The Joint Corp. has a 52 week low of $1.96 and a 52 week high of $5.07.

The Joint Corp. (NASDAQ:JYNT) last posted its earnings results on Thursday, August 10th. The company reported ($0.08) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.09) by $0.01. The Joint Corp. had a negative return on equity of 103.25% and a negative net margin of 48.08%. The business had revenue of $6.02 million during the quarter, compared to the consensus estimate of $5.76 million. Equities analysts forecast that The Joint Corp. will post ($0.33) EPS for the current year.

The Joint Corp. Company Profile

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Receive News & Ratings for The Joint Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Joint Corp. and related companies with MarketBeat.com's FREE daily email newsletter.